Search - tctmd.com

Displaying 721 - 740 of 935

Sort: Relevancy | Date

News Daily News

PARTNER Data Provide More Evidence of Mortality Impact of Post-TAVR Regurgitation

October 10, 2014

News Daily News

Ischemia Testing Foretells Prognosis in Diabetic Patients with Asymptomatic CAD

Caitlin E. Cox

October 03, 2014

News Daily News

IABP Therapy May Benefit Patients With Large STEMI, Persistent Ischemia Post-PCI

Caitlin E. Cox

October 03, 2014

News Conference News TCT 2014

Symplicity Flex: No Benefit of Renal Denervation in Mild Resistant Hypertension

September 16, 2014

News Industry News

Randomized Sham-Controlled Trial Examines Blood Pressure Effects of Renal Denervation in Patients with Mild Refractory Hypertension

September 16, 2014

News Conference News TCT 2014

Experts Debate Future of Renal Denervation

September 16, 2014

News Conference News TCT 2014

SYMPLICITY HTN-3 Substudy Examines BP Response Factors in African Americans

Yael L. Maxwell

September 15, 2014

News Industry News

Twelve-Month Data from St. Jude Medical EnligHTN Renal Denervation System Show Continued Safety and Efficacy for Patients

September 13, 2014

News Conference News TCT 2014

SYMPLICITY HTN-3: Crossover Patients Strengthen the Case for Renal Denervation

September 13, 2014

News Conference News TCT 2014

Experts Debate Future of Renal Denervation Therapy

September 13, 2014

News Daily News

Incomplete Revascularization Linked to Poorer Outcomes in TAVR Patients With CAD

September 11, 2014

News Daily News

High Reactivity on Aspirin Just Before PCI Linked to Worse Outcomes

September 02, 2014

News Conference News ESC 2014

SYMPLICITY HTN-3: Renal Denervation Still Safe, Not Effective at 1 Year

Todd Neale

September 01, 2014

News Conference News ESC 2014

NOMI: Nitric Oxide May Do Wonders for STEMI But Not When Mixed with Nitroglycerin

Caitlin E. Cox

September 01, 2014

News Conference News ESC 2014

SOLID-TIMI 52: Darapladib Fails to Reduce Adverse Events After ACS

Yael L. Maxwell

August 31, 2014

News Industry News

Large-scale Study Confirms Growing Body of Clinical Evidence for the St. Jude Medical Quadripolar System

August 31, 2014

News Industry News

Boston Scientific Announces Primary Endpoint Results of NECTAR-HF Clinical Trial

August 30, 2014

News Daily News

Similar Survival Benefits from Surgery, MitraClip in Symptomatic, High-Risk Mitral Regurgitation

L.A. McKeown

August 20, 2014

News Industry News

Novartis to showcase heart failure leadership at ESC Congress 2014 with results on new first of its type medicine LCZ696

August 11, 2014

News Daily News

EVA-3S: Carotid Stenting, Endarterectomy Show Comparable Long-term Efficacy

L.A. McKeown

August 07, 2014

Advertisement

PARTNER Data Provide More Evidence of Mortality Impact of Post-TAVR Regurgitation

Ischemia Testing Foretells Prognosis in Diabetic Patients with Asymptomatic CAD

IABP Therapy May Benefit Patients With Large STEMI, Persistent Ischemia Post-PCI

Symplicity Flex: No Benefit of Renal Denervation in Mild Resistant Hypertension

Randomized Sham-Controlled Trial Examines Blood Pressure Effects of Renal Denervation in Patients with Mild Refractory Hypertension

Experts Debate Future of Renal Denervation

SYMPLICITY HTN-3 Substudy Examines BP Response Factors in African Americans

Twelve-Month Data from St. Jude Medical EnligHTN Renal Denervation System Show Continued Safety and Efficacy for Patients

SYMPLICITY HTN-3: Crossover Patients Strengthen the Case for Renal Denervation

Experts Debate Future of Renal Denervation Therapy

Incomplete Revascularization Linked to Poorer Outcomes in TAVR Patients With CAD

High Reactivity on Aspirin Just Before PCI Linked to Worse Outcomes

SYMPLICITY HTN-3: Renal Denervation Still Safe, Not Effective at 1 Year

NOMI: Nitric Oxide May Do Wonders for STEMI But Not When Mixed with Nitroglycerin

SOLID-TIMI 52: Darapladib Fails to Reduce Adverse Events After ACS

Large-scale Study Confirms Growing Body of Clinical Evidence for the St. Jude Medical Quadripolar System

Boston Scientific Announces Primary Endpoint Results of NECTAR-HF Clinical Trial

Similar Survival Benefits from Surgery, MitraClip in Symptomatic, High-Risk Mitral Regurgitation

Novartis to showcase heart failure leadership at ESC Congress 2014 with results on new first of its type medicine LCZ696

EVA-3S: Carotid Stenting, Endarterectomy Show Comparable Long-term Efficacy

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content